Vaidya Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 11-12-2024
- Paid Up Capital ₹ 2.34 Cr
as on 11-12-2024
- Company Age 20 Year, 12 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 7.00 Cr
as on 11-12-2024
- Revenue 10.40%
(FY 2022)
- Profit 29.99%
(FY 2022)
- Ebitda 14.19%
(FY 2022)
- Net Worth 40.17%
(FY 2022)
- Total Assets 28.65%
(FY 2022)
About Vaidya Nutraceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.34 Cr.
The company has closed loans amounting to ₹7.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Poonam Sharma, Shailesh Sharma, and Seema Sharma serve as directors at the Company.
- CIN/LLPIN
U24233DL2004PTC131000
- Company No.
131000
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Dec 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vaidya Nutraceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailesh Sharma  | Director | 30-Dec-2004 | Current |
| Poonam Sharma | Director | 20-Dec-2023 | Current |
| Seema Sharma | Director | 15-Mar-2016 | Current |
Financial Performance and Corporate Structure Insights of Vaidya Nutraceuticals.
Vaidya Nutraceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.4% increase. The company also saw a substantial improvement in profitability, with a 29.99% increase in profit. The company's net worth Soared by an impressive increase of 40.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaidya Nutraceuticals?
In 2022, Vaidya Nutraceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 May 2007 | ₹3.50 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 17 Jan 2007 | ₹1.50 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 30 Oct 2006 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Vaidya Nutraceuticals?
Unlock and access historical data on people associated with Vaidya Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaidya Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaidya Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
